• 01.29.24

    Lykos MDMA Submission Series A

    On December 11, 2023, following positive results from two published Phase 3 studies, MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the Federal Drug Administration (FDA) for an investigational MDMA-assisted therapy for persons suffering from post-traumatic ...

  • 12.13.23

    FDA Receives Application for Approval of MDMA-Assisted Therapy

    On December 12, 2023, the MAPS Public Benefit Corporation (MAPS PBC) announced the submission of a marketing application to the U.S. Food and Drug Administration (FDA) for MDMA (midomafetamine capsules) in combination with psychological intervention by a qualified health care provider (including ...

  • 07.21.20

    ADA Website Litigation Reaches the Cannabis Industry

    For the past decade, plaintiffs’ lawyers have been trolling the Internet for websites that are incompatible with screen-reader technology used by blind people to navigate the web.

  • 01.27.20

    Retail and Consumer Products Law Roundup January 2020

    On January 14, a new version of the proposed Washington Privacy Act, Senate Bill 6281, was introduced in the state Senate.

  • 01.16.20

    Burnt Out? SAFE Banking Act Faces Senate Opposition

    After making it farther than any prior legislation enabling financial services to be provided to legitimate marijuana businesses, the bill appears to be stalled in the Senate.

  • 12.24.19

    Regulators Ease Oversight of Hemp Businesses

    In new guidance, banking regulators eased oversight of financial institutions working with hemp-related businesses.

  • 08.13.19

    Retail and Consumer Products Law Roundup August 2019

    In the decade since amendments to the landmark Americans with Disabilities Act (ADA) took effect, businesses across all industries have confronted constant legal challenges concerning workplace and retail premises access, as well as complaints about online accommodations for people whose vision and ...

  • 07.29.19

    National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer

    On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s marketing of its CBD-based products for ...

  • 06.06.19

    Slow Burn: California Makes Another Attempt to Pass a Marijuana Bank Bill

    The movement to provide a limited bank charter to serve marijuana businesses in California inched forward when the California Senate approved SB 51 by an almost unanimous vote, sending the measure to the Assembly for review.

  • 05.22.19

    State AGs, ABA Back Bill On Financial Services For Cannabis

    Support continues to build for the Secure and Fair Enforcement (SAFE) Banking Act, with a coalition of 38 state and territorial Attorneys General as well as the American Bankers Association (ABA) writing to lawmakers to urge passage of the bill.

manatt-black

ATTORNEY ADVERTISING

pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved